Thyrocare Technologies Limited has scheduled a meeting of the Board of Directors for Thursday, October 29, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026.
The company has implemented a trading window closure for designated persons and their immediate relatives, effective from October 01, 2026. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) and the Company's internal code of conduct. The trading window will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30, 2026.
The disclosure was made to both National Stock Exchange of India Limited and BSE Limited as required by Regulation 29 of the SEBI Listing Regulations. The communication was signed by Brijesh Kumar, Company Secretary and Compliance Officer, on October 22, 2026 at 15:41:15 IST.